Literature DB >> 21777691

Target-drug interactions: first principles and their application to drug discovery.

Sara Núñez1, Jennifer Venhorst, Chris G Kruse.   

Abstract

In this review, we begin by introducing the basic principles of kinetics and thermodynamics of target-drug binding within the context of drug discovery. In addition, we present a meta-analysis of the recent literature describing the kinetic and thermodynamic resolution of successful clinical candidates with diverse mechanisms of action. We finish by discussing the best practices in the triage and chemical optimization towards clinical candidates with maximal in vivo efficacy devoid of adverse events.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21777691     DOI: 10.1016/j.drudis.2011.06.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  37 in total

Review 1.  On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Authors:  Georges Vauquelin; Isabelle Van Liefde; David C Swinney
Journal:  Br J Pharmacol       Date:  2016-03-15       Impact factor: 8.739

2.  Mobility of Histidine Side Chains Analyzed with 15N NMR Relaxation and Cross-Correlation Data: Insight into Zinc-Finger-DNA Interactions.

Authors:  Catherine A Kemme; Ross H Luu; Chuanying Chen; Channing C Pletka; B Montgomery Pettitt; Junji Iwahara
Journal:  J Phys Chem B       Date:  2019-04-18       Impact factor: 2.991

3.  Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time.

Authors:  Georges Vauquelin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-28       Impact factor: 3.000

4.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

5.  'Partial' competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models.

Authors:  Georges Vauquelin; David Hall; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

6.  Reversible silencing of endogenous receptors in intact brain tissue using 2-photon pharmacology.

Authors:  Silvia Pittolo; Hyojung Lee; Anna Lladó; Sébastien Tosi; Miquel Bosch; Lídia Bardia; Xavier Gómez-Santacana; Amadeu Llebaria; Eduardo Soriano; Julien Colombelli; Kira E Poskanzer; Gertrudis Perea; Pau Gorostiza
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-13       Impact factor: 11.205

Review 7.  Link between a high k on for drug binding and a fast clinical action: to be or not to be?

Authors:  Georges Vauquelin
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

8.  Dissociation kinetics of the streptavidin-biotin interaction measured using direct electrospray ionization mass spectrometry analysis.

Authors:  Lu Deng; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2012-12-18       Impact factor: 3.109

9.  Effects of target binding kinetics on in vivo drug efficacy: koff , kon and rebinding.

Authors:  Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

Review 10.  Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo.

Authors:  Georges Vauquelin
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.